{
    "clinical_study": {
        "@rank": "38628", 
        "arm_group": {
            "arm_group_label": "women during fertility treatment"
        }, 
        "biospec_descr": {
            "textblock": "Blood tests (hormones level)"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the relation between estrogen and progesterone\n      levels, and between dryness of the eyes, in women during their fertile years."
        }, 
        "brief_title": "Estrogen and the Outer Eye in Women During Fertility Treatment", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Dry Eye Syndromes", 
        "condition_browse": {
            "mesh_term": [
                "Dry Eye Syndromes", 
                "Keratoconjunctivitis Sicca"
            ]
        }, 
        "detailed_description": {
            "textblock": "Women during their fertility treatments will be submitted to the research. The research will\n      include 3 meetings with a doctor from the ophthalmology department. Each meeting will be\n      individual for each participant of the research.\n\n      The meetings will take place during the day of regular appointment of the participant to the\n      fertility clinic.\n\n      Meeting #1:\n\n      During first visit to the fertility clinic for the stimulation process.\n\n      During this day will be done:\n\n      1.Submission of the patient to the research and signing on letter of agreement 2.Blood tests\n      for estrogen, progesterone, luteinizing hormone (LH) 3.Eye examination: 3a. Filling of\n      Schein Questionnaire 3b. Examination of the external eye: 1.microscope, 2.Schirmer test\n      (paper strips inserted into the eye for several minutes to measure the production of tears),\n      3. tear break up time test (checking the eye with the fluorescein light after painting the\n      eye with fluorescein dye) 3c. Checking the Intra Ocular Pressure with Tonometer\n\n      Meeting #2:\n\n      During visit to the fertility clinic for the egg collection (about 10 days after meeting #1)\n\n      During this day will be done:\n\n      1.Blood tests for estrogen, progesterone, luteinizing hormone (LH) 2.Eye examination: 2a.\n      Filling of Schein Questionnaire 2b. Examination of the external eye: 1.microscope,\n      2.Schirmer test (paper strips inserted into the eye for several minutes to measure the\n      production of tears), 3. tear break up time test (checking the eye with the fluorescein\n      light after painting the eye with fluorescein dye) 2c. Checking the Intra Ocular Pressure\n      with Tonometer\n\n      Meeting #3:\n\n      During visit to the fertility clinic for the pregnancy test (about 14 days after meeting #2)\n\n      During this day will be done:\n\n        1. Blood tests for estrogen, progesterone, luteinizing hormone (LH)\n\n        2. Eye examination:\n\n      2a. Filling of Schein Questionnaire 2b. Examination of the external eye: 1.microscope,\n      2.Schirmer test (paper strips inserted into the eye for several minutes to measure the\n      production of tears), 3. tear break up time test (checking the eye with the fluorescein\n      light after painting the eye with fluorescein dye) 2c. Checking the Intra Ocular Pressure\n      with Tonometer\n\n      Collection and summary of all the data End of the research"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  women during fertility treatment\n\n          -  without any known eye diseases\n\n          -  no current or past history of treatment against dry eye\n\n        Exclusion Criteria:\n\n          -  known eye disease\n\n          -  current or past history of treatment against dry eye"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "37 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "fertility clinic patients"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02072122", 
            "org_study_id": "EOEDFT-2"
        }, 
        "intervention_browse": {
            "mesh_term": "Estrogens"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "dry eye", 
            "fertility treatment", 
            "Meibomian gland dysfunction", 
            "supra physiologic estrogen level"
        ], 
        "lastchanged_date": "February 25, 2014", 
        "number_of_groups": "1", 
        "official_title": "The Influence of the Hormonal Fertility Treatment of Women, on the Eye Surface and the Eye Dryness", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Evidence of clinically definite dry eye confirmed by Schirmer test and tear break up time test", 
            "safety_issue": "No", 
            "time_frame": "24 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02072122"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Evidence of clinically definite dry eye confirmed by Schirmer test and tear break up time test during each on of the meetings #1,#2 (day 0, day 10)", 
            "safety_issue": "No", 
            "time_frame": "0 days, 10 days"
        }, 
        "source": "Meir Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meir Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "4 Weeks", 
        "verification_date": "February 2014"
    }
}